Wu Jia-Rong, Moser Debra K
Jia-Rong Wu, PhD, RN Post-doctoral Fellow, School of Nursing, University of North Carolina at Chapel Hill. Debra K. Moser, PhD, RN Professor and Linda C. Gill Chair of Cardiovascular Nursing and Director, RICH Heart Program, College of Nursing, University of Kentucky, Lexington.
J Cardiovasc Nurs. 2018 Jan/Feb;33(1):40-46. doi: 10.1097/JCN.0000000000000427.
Heart failure (HF) symptoms such as dyspnea are common and may precipitate hospitalization. Medication nonadherence is presumed to be associated with symptom exacerbations, yet how HF symptoms, medication adherence, and hospitalization/death are related remains unclear.
The aim of this study was to explore the relationships among HF symptoms, medication adherence, and cardiac event-free survival in patients with HF.
At baseline, patient demographics, clinical data, and HF symptoms were collected in 219 patients with HF. Medication adherence was monitored using the Medication Event Monitoring System. Patients were followed for up to 3.5 years to collect hospitalization and survival data. Logistic regression and survival analyses were used for the analyses.
Patients reporting dyspnea or ankle swelling were more likely to have poor medication adherence (P = .05). Poor medication adherence was associated with worse cardiac event-free survival (P = .006). In Cox regression, patients with HF symptoms had 2 times greater risk for a cardiac event than patients without HF symptoms (P = .042). Heart failure symptoms were not a significant predictor of cardiac event-free survival after entering medication adherence in the model (P = .091), indicating mediation.
Medication adherence was associated with fewer HF symptoms and lower rates of hospitalization and death. It is important to develop interventions to improve medication adherence that may reduce HF symptoms and high hospitalization and mortality in patients with HF.
诸如呼吸困难等心力衰竭(HF)症状很常见,且可能促使患者住院。据推测,药物治疗依从性差与症状加重有关,但HF症状、药物治疗依从性以及住院/死亡之间的关系仍不清楚。
本研究旨在探讨HF患者的HF症状、药物治疗依从性和无心脏事件生存期之间的关系。
在基线时,收集了219例HF患者的人口统计学资料、临床数据和HF症状。使用药物事件监测系统监测药物治疗依从性。对患者进行长达3.5年的随访,以收集住院和生存数据。采用逻辑回归和生存分析进行分析。
报告有呼吸困难或脚踝肿胀的患者更有可能药物治疗依从性差(P = .05)。药物治疗依从性差与较差的无心脏事件生存期相关(P = .006)。在Cox回归分析中,有HF症状的患者发生心脏事件的风险是没有HF症状患者的2倍(P = .042)。在模型中纳入药物治疗依从性后,HF症状并非无心脏事件生存期的显著预测因素(P = .091),表明存在中介作用。
药物治疗依从性与较少的HF症状以及较低的住院率和死亡率相关。开展干预措施以提高药物治疗依从性很重要,这可能会减轻HF患者的症状,并降低其高住院率和死亡率。